[Molecular bases of hereditary hyperekplexia]
- PMID: 19085882
[Molecular bases of hereditary hyperekplexia]
Abstract
Introduction: Hereditary hyperekplexia is a rare clinical syndrome typically characterized by sudden and generalized startle in response to trivial but unexpected tactile or acoustic stimulations. Typically it is accompanied by a temporally but complete muscular rigidly, and usually it manifests shortly after birth. Some affected infants die suddenly from lapses in cardiorespiratory function. Mental development usually is normal.
Aim: To summarize and update the molecular bases underlying the hereditary hyperekplexia syndrome.
Development: Approximately 30% of the individuals suffering hereditary hyperekplexia show mutations on a gene located on chromosome 5q32 with a dominant or recessive trait. This gene encodes the alpha subunit of the strychnine-sensitive glycine receptor, which plays a crucial role in inhibitory glycinergic neurotransmission that process sensory and motor information. About 70% of the patients with hyperekplexia do not show genetic defects in the glycine receptor gene; this suggested that additional genes might be affected in this disease. Recent studies have reveals that mutations in the neuronal glycine transporter GLYT2 are a second major cause of hyperekplexia.
Conclusions: Hereditary hyperekplexia is a complex genetic disease in which several genes can be implicated, all of them directly or indirectly involved in inhibitory glycinergic neurotransmission. Two major proteins involved in hyperekplexia are the strychnine-sensitive glycine receptor (GlyR) and the neuronal glycine transporter GLYT2. Implication of secondary additional accompanying or interacting proteins in glycinergic terminals are not ruled out.
Similar articles
-
Hyperekplexia-associated mutations in the neuronal glycine transporter 2.Neurochem Int. 2019 Feb;123:95-100. doi: 10.1016/j.neuint.2018.05.014. Epub 2018 May 30. Neurochem Int. 2019. PMID: 29859229 Review.
-
Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5. doi: 10.1016/j.bbrc.2006.07.080. Epub 2006 Jul 26. Biochem Biophys Res Commun. 2006. PMID: 16884688
-
GLRB is the third major gene of effect in hyperekplexia.Hum Mol Genet. 2013 Mar 1;22(5):927-40. doi: 10.1093/hmg/dds498. Epub 2012 Nov 25. Hum Mol Genet. 2013. PMID: 23184146
-
Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission.Neuron. 2006 Nov 22;52(4):679-90. doi: 10.1016/j.neuron.2006.09.035. Neuron. 2006. PMID: 17114051
-
[Familial hyperekplexia: startle disease. Clinical, electrophysiological and genetic study of a family].Rev Neurol (Paris). 1996 Jun-Jul;152(6-7):447-50. Rev Neurol (Paris). 1996. PMID: 8944241 Review. French.
Cited by
-
New treatment paradigms in neonatal metabolic epilepsies.J Inherit Metab Dis. 2009 Apr;32(2):204-13. doi: 10.1007/s10545-009-1045-8. Epub 2009 Feb 24. J Inherit Metab Dis. 2009. PMID: 19234868 Review.